《CB Insights：2025年Q1全球数字健康状况报告：私募市场交易、投融资和退出数据及分析（英文版）（84页）.pdf》由会员分享，可在线阅读，更多相关《CB Insights：2025年Q1全球数字健康状况报告：私募市场交易、投融资和退出数据及分析（英文版）（84页）.pdf（84页珍藏版）》请在三个皮匠报告上搜索。

1、State of Digital HealthGlobal|Q1 2025Global data and analysis on dealmaking,funding,and exits by private market digital health companiesState of Digital Health2 2Make smartertech decisions.Our platform will help you discover,understand,and manage your response to emerging tech.Make confident tech de

2、cisions that drive growth,improve operations,and beat the competition with CB Insights.IIIITry our platform free!Sign up for a free trialState of Digital Health3 3“Steal”our data.Download the underlying data in this report.If you create any analysis or visualizations with this data,send it our way a

3、nd you could be featured in the CBI newsletter.us on social LinkedIn X(Twitter)InstagramIIIIDownload the raw dataSign up for a free trialTL;DR4Your rundown ondigital health in Q12546%Mega-rounds share of digital health funding in Q125.Mega-rounds($100M+deals)totaled$2.5B across 11 deals more than do

4、uble Q424s total.These rounds captured 46%of all digital health funding,the highest share since Q421.AI-focused startups secured 8 of these 11 deals,including Isomorphic Labs,Truveta,and Innovaccer.See the data 60%Of funding went to AI-focused companies.AI startups raised$3.2B in Q1 60%of all digita

5、l health funding,up from 41%in 2024.Deal volume rose 6%QoQ,even as overall deals declined.Top-funded areas included AI-derived small molecule drugs and clinical documentation tools.See the data 27%Uptick in M&A exits in Q125.M&A activity surged 27%QoQ to 51 deals,the highest level since Q123 This in

6、crease was driven entirely by US companies,while M&A in Europe and Asia declined.The quarter featured two$1B+acquisitions:CentralReach($1.6B)and Alto Pharmacy($1.5B),highlighting renewed buyer interest in scaled platforms with proprietary data.See the data 6New digital health unicorns.Q125 saw 6 new